Scholarlink

<p>Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with chemoresistance posing major treatment challenges. Here, we investigated the anticancer potential of pyrazolo[4,3-<i>e</i>]tetrazolo[1,5-<i>b</i>][1,2,4]triazine sulfonamides (MM129 and MM137) in combination with the ATM inhibitor KU-60,019 in HCT-116 and HT-29 CRC models. Combinatorial treatment significantly decreased cell viability, suppressed proliferation (BrdU and Ki-67), and increased neutral comet and γH2AX-associated DNA damage parameters compared to single-agent treatments. Cell death analyses showed mainly apoptosis-associated changes, while partial protection by NEC-1 suggests that additional non-apoptotic mechanisms may contribute under selected conditions. Our results indicate that MM compounds exhibit measurable anticancer activity in 3D spheroid models and that their combination with ATM inhibition modulates both viability and spheroid morphology, as reflected by changes in ATP levels, core size, and diffusion parameters. Further optimization and mechanistic studies are required to determine the extent and basis of any combinatorial benefit in this context.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

ATM inhibition potentiates the anticancer activity of pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides in colorectal cancer cells in vitro

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年8月3日

查看全文
  • Mateusz Kciuk,
  • Katarzyna Wanke,
  • Mariusz Mojzych,
  • Elżbieta Płuciennik,
  • Renata Kontek

摘要

Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with chemoresistance posing major treatment challenges. Here, we investigated the anticancer potential of pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides (MM129 and MM137) in combination with the ATM inhibitor KU-60,019 in HCT-116 and HT-29 CRC models. Combinatorial treatment significantly decreased cell viability, suppressed proliferation (BrdU and Ki-67), and increased neutral comet and γH2AX-associated DNA damage parameters compared to single-agent treatments. Cell death analyses showed mainly apoptosis-associated changes, while partial protection by NEC-1 suggests that additional non-apoptotic mechanisms may contribute under selected conditions. Our results indicate that MM compounds exhibit measurable anticancer activity in 3D spheroid models and that their combination with ATM inhibition modulates both viability and spheroid morphology, as reflected by changes in ATP levels, core size, and diffusion parameters. Further optimization and mechanistic studies are required to determine the extent and basis of any combinatorial benefit in this context.